80 Years and Older Vision & Hearing Important Persons Project (80VIP)

Information

  • Research Project
  • 10129237
  • ApplicationId
    10129237
  • Core Project Number
    R34EY031427
  • Full Project Number
    1R34EY031427-01A1
  • Serial Number
    031427
  • FOA Number
    PAR-19-231
  • Sub Project Id
  • Project Start Date
    4/1/2021 - 3 years ago
  • Project End Date
    2/28/2023 - a year ago
  • Program Officer Name
    EVERETT, DONALD F
  • Budget Start Date
    4/1/2021 - 3 years ago
  • Budget End Date
    2/28/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
    A1
  • Award Notice Date
    3/30/2021 - 3 years ago

80 Years and Older Vision & Hearing Important Persons Project (80VIP)

Project Summary/Abstract Previous prevalence studies include only small and infrequent estimates of vision, hearing, balance loss or dual sensory loss (DSL) in older adults over aged 80 years, which creates a large gap in knowledge in this important age group. This age group will increase by 600% in the next 30 years, an increase faster than any other age strata, or minority group. Many older patients admitted into institutionalized care have high proportions of untreated VL/HL/DSL. Unfortunately, little data exists on the effectiveness of treating VL/HL/DSL to decrease morbidity, increase quality of life, and decrease caregiver burden and cost in this susceptible age group. This demonstrates a need to understand the prevalence and impact of undiagnosed VL/HL/DSL in community dwelling older adults. Age-related hearing and vision impairment will each rank within the top 10 burdens of disease in middle- and high-income countries in the next 20 years. This evaluation of older persons fits with the National Institutes of Health's new Inclusion Across the Lifespan policy that was implemented in January 2019. The R34 planning grant is to support the development of a detailed infrastructure for a future ?80 Years and Older Vision & Hearing Important Persons Project (80VIP)? under the UG1 Cooperative Agreement funding mechanism. This special population (age >80 years) is rarely included in population-based prevalence surveys or clinical trials, and may require more effort, or new methods to recruit and enroll participants when compared to previous studies. We will also develop a comprehensive manual of procedures, which includes standards for collecting ocular and biometric data, includes new instrumentation, and allows comparisons with previous groundbreaking prevalence surveys. We will also evaluate the burden, feasibility, and suitability of the protocol from the perspective of key stakeholders, which increases the likelihood of a successfully transition into a larger UG1 study; and we will develop a statistical analysis plan that addresses all of the proposed future hypotheses. The study team has the expertise to conduct this proposal, and move this planning grant proposal toward a successful UG1 application. In the future, the experiences and data from this proposal will help plan health resources requirements in the future, and interventions to augment healthy living, prevent morbidity such as institutionalized care, and reduce the high economic costs of vision and hearing loss.

IC Name
NATIONAL EYE INSTITUTE
  • Activity
    R34
  • Administering IC
    EY
  • Application Type
    1
  • Direct Cost Amount
    159267
  • Indirect Cost Amount
    93078
  • Total Cost
    252345
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    867
  • Ed Inst. Type
  • Funding ICs
    NEI:252345\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZEY1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    LEGACY EMANUEL HOSPITAL AND HEALTH CENTER
  • Organization Department
  • Organization DUNS
    050973098
  • Organization City
    Portland
  • Organization State
    OR
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    972322003
  • Organization District
    UNITED STATES